| [1] |
Foulkes WD.Inherited susceptibility to common cancers.N Engl J Med,2008,359:2143-2153.
|
| [2] |
Palacios J,Robles-Frias MJ,Castilla MA,et al.The molecular pathology of hereditary breast cancer.Pathobiology,2008,75:85-94.
|
| [3] |
Wu LC,Wang ZW,Tsan JT,et al.Identification of a RING protein that can interact in vivo with the BRCA1 gene product.Nature Genet,1996,14,430-440.
|
| [4] |
Rodriguez JA,Schuchner S,Au WW,et al.Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapototic activity and is regulated by dimerization with BRCA1.Oncogene,2004,23:1809-1820.
|
| [5] |
Irminger-Finger I,Leung WC.BRCA1-dependent and independent functions of BARD1.Int J Biochem Cell Biol,2002,34:582-587.
|
| [6] |
Hashizume R,Fukuda M,Meada I,et al.The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.J Biol Chem,2001,276:14537-14540.
|
| [7] |
Oyake D,Nishikawa H,Koizuka I,et al.Targeted substrate degradation by an engineered double RING ubiquitin ligase.Biochem Biophys Res Commun,2002,295:370-375.
|
| [8] |
Ruffner H,Joazeiro CA,Hemmati D,et al.Cancer-predisposing mutations within the RING domain of BRCA1:loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity.Proc Natl Acad Sci USA,2001,98:5134-5139.
|
| [9] |
Starita LM,Machida Y,Sankaran S,et al.BRCA1-dependent ubiquitination ofγ-tubulin regulates centrosome number.Mol Cell Biol,2004,24:8457-8466.
|
| [10] |
Grisendi S,Bernardi R,Rossi M.et al.Role of nucleophosmin in embryonic development and tumorigenesis.Nature,2005,437:147-153.
|
| [11] |
Chen A,Kleiman FE,Manley JL,et al.Autoubiquitination of the BRCA1-BARD1 RINGubiquitin ligase.J Biol Chem,2002,277:22085-22092.
|
| [12] |
Anderson SF,Schigiel BP,Nakajima T,et al.BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.Nature Genet,1998,19:254-256.
|
| [13] |
Ayi TC,Tsan JT,Hwang LY,et al.Conservation of function and primary structure in the BRCA1-associated RING domain(BARD1)protein.Oncogene,1998,17:2143-2148.
|
| [14] |
Irminger-Finger I,Soriano JV,Vaudan G,et al.In vitro repression of Brca1-associated RING domain gene,Bard1,induces phenotypic changes in mammary epithelial cells.J Cell Biol,1998,143:1329-1339.
|
| [15] |
Irminger-Finger I,Leung WC,Li J,et al.Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis.Mol Cell,2001,8:1255-1266.
|
| [16] |
Feki A,Jefford CE,Bernardi P,et al.BARD1 induces apoptosis by catalyzing phosphorylation of p53 by DNAdamage response kinase.Oncogene,2005,24:3726-3736.
|
| [17] |
Jefford CE,Feki A,Harb J,et al.Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity.Oncogene,2004,23:3509-3520.
|
| [18] |
Thai TH,Du F,Tsan JT,et al.Mutations in the BRCA1-associated RING domain(BARD1)gene in primary breast,ovarian and uterine cancers.Hum Mol Genet,1998,7:195-202.
|
| [19] |
Ghimenti C,Sensi E,Presciuttini S,et al.Germline mutations of the BRCA1-associated ring domain(BARD1)gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.Genes Chromosomes Cancer,2002,33:235-242.
|
| [20] |
Winqvist R.Mutation screening of the BARD1 gene:evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer.J Med Genet,2004,41:e114.
|
| [21] |
Ishitobi M,Miyoshi Y,Hasegawa S,et al.Mutational analysis of BARD1 in familial breast cancer patients in Japan.Cancer Lett,2003,200:1-7.
|
| [22] |
Wu JY,Vlastos AT,Pelte MF,et al.Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis.Int J Cancer,2006,118:1215-1226.
|